LeadingAge is seeking feedback on the impact of the long-stay antipsychotics quality measure on Nursing Home Care Compare. This measure provides information on rates of antipsychotic usage in nursing homes and is utilized in the Five Star Quality Rating System. LeadingAge is a member of Project PAUSE, a coalition advocating for changes to the quality measure due to the relative failure of the measure to distinguish between appropriate and inappropriate antipsychotic usage and we would like your feedback. What has been the impact of this quality measure in your nursing home? Have your star ratings suffered, and what has been the impact of that? Is your nursing home more reluctant to admit potential residents who are already prescribed antipsychotics? Have you felt pressured to deprescribe for residents who were appropriately prescribed antipsychotics? Please share your input by emailing Jodi Eyigor jeyigor@leadingage.org. Note that we will not share any identifying information – we are simply looking for concrete examples of the impact of this measure.